Total Payments
$1,217
2024 Payments
$21.03
Companies
8
Transactions
53
Medicare Patients
3,448
Medicare Billing
$496,840
Payment Breakdown by Category
Food & Beverage$1,217 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,217 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $526.34 | 21 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $191.95 | 5 | $0 (2023) |
| PFIZER INC. | $172.31 | 12 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $150.24 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $90.94 | 8 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $44.75 | 2 | $0 (2024) |
| Abbott Laboratories | $21.82 | 1 | $0 (2022) |
| Allergan Inc. | $18.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.03 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($21.03) |
| 2023 | $160.36 | 3 | AstraZeneca Pharmaceuticals LP ($127.48) |
| 2022 | $126.90 | 8 | E.R. Squibb & Sons, L.L.C. ($83.56) |
| 2021 | $112.15 | 8 | E.R. Squibb & Sons, L.L.C. ($97.34) |
| 2020 | $165.31 | 4 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2019 | $330.44 | 10 | Novartis Pharmaceuticals Corporation ($154.58) |
| 2018 | $116.08 | 9 | Janssen Pharmaceuticals, Inc ($46.87) |
| 2017 | $184.33 | 10 | E.R. Squibb & Sons, L.L.C. ($98.49) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $127.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Cardiovascular | ||||||
| 02/24/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.92 | General |
| Category: Cardiovascular | ||||||
| 08/25/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Cardiovascular | ||||||
| 08/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Cardiovascular | ||||||
| 06/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Cardiovascular | ||||||
| 06/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Cardiovascular | ||||||
| 05/13/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/06/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Cardiovascular | ||||||
| 10/06/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Cardiovascular | ||||||
| 09/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 08/11/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Cardiovascular | ||||||
| 04/07/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Cardiovascular | ||||||
| 03/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: Cardiovascular | ||||||
| 03/16/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Cardiovascular | ||||||
| 01/14/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Cardiovascular | ||||||
| 06/17/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/10/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/30/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/28/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 10/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 723 | 1,126 | $247,072 | $102,722 |
| 2022 | 9 | 910 | 1,651 | $322,447 | $133,588 |
| 2021 | 8 | 970 | 1,689 | $318,066 | $139,668 |
| 2020 | 8 | 845 | 1,414 | $264,555 | $120,862 |
Total Patients
3,448
Total Services
5,880
Medicare Billing
$496,840
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 240 | 580 | $87,552 | $39,337 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 203 | 216 | $83,583 | $31,052 | 37.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 189 | 211 | $47,394 | $20,873 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 78 | $19,749 | $8,079 | 40.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,697 | $1,803 | 38.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 24 | 24 | $4,097 | $1,578 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 313 | 1,005 | $147,773 | $60,863 | 41.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 155 | 166 | $62,355 | $26,233 | 42.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 236 | 266 | $57,994 | $23,927 | 41.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 94 | 96 | $32,878 | $13,786 | 41.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 47 | 48 | $6,524 | $3,033 | 46.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $4,850 | $1,969 | 40.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 23 | $5,590 | $1,881 | 33.6% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 14 | 17 | $2,851 | $1,152 | 40.4% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 12 | $1,632 | $744.30 | 45.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 353 | 1,015 | $145,612 | $63,206 | 43.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 270 | 309 | $65,851 | $28,887 | 43.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 134 | 146 | $53,579 | $23,859 | 44.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 92 | 95 | $31,767 | $14,377 | 45.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 70 | 72 | $9,513 | $4,448 | 46.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $4,965 | $2,122 | 42.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 20 | 20 | $5,070 | $2,009 | 39.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 12 | 13 | $1,709 | $761.16 | 44.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 324 | 860 | $120,604 | $53,811 | 44.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 134 | 143 | $51,238 | $24,515 | 47.8% |
About Dr. Manasi Revankar, D.O
Dr. Manasi Revankar, D.O is a Family Medicine healthcare provider based in Phillipsburg, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1619127024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manasi Revankar, D.O has received a total of $1,217 in payments from pharmaceutical and medical device companies, with $21.03 received in 2024. These payments were reported across 53 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,217).
As a Medicare-enrolled provider, Revankar has provided services to 3,448 Medicare beneficiaries, totaling 5,880 services with total Medicare billing of $496,840. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Phillipsburg, NJ
- Active Since 09/22/2008
- Last Updated 09/02/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619127024
Products in Payments
- ELIQUIS (Drug) $604.67
- ENTRESTO (Drug) $176.10
- FARXIGA (Drug) $127.48
- XARELTO (Drug) $90.94
- CHANTIX (Drug) $76.95
- LifeVest (Device) $44.75
- BRILINTA (Drug) $22.76
- CONFIRM RX (Device) $21.82
- AVYCAZ (Drug) $18.25
- CAMZYOS (Drug) $17.03
- LEQVIO (Drug) $15.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Phillipsburg
Dr. Ana Gomes, Do, Cmd, DO, CMD
Family Medicine — Payments: $590.76
Family Medicine $590.76
Peter Sugarbaker
Family Medicine — Payments: $495.40
Family Medicine $495.40
Frank Lombardi, Do, DO
Family Medicine — Payments: $338.19
Family Medicine $338.19
Dr. Thaddeus Aversa, Do, DO
Family Medicine — Payments: $275.26
Family Medicine $275.26
Ileana Ortiz-Evans, Md, MD
Family Medicine — Payments: $271.24
Family Medicine $271.24
Tyson Wisinger, M.d, M.D
Family Medicine — Payments: $265.95
Family Medicine $265.95